Chad vs Niger: Cause of death, by non-communicable diseases, ages 5-14, female
Chad
17.3%
in 2021
Niger
18.9%
in 2021
Chad rank
164th
Niger rank
161st
Cause of death, by non-communicable diseases, ages 5-14, female over time
- Chad
- Niger
How they compare
Niger currently reports 18.9% against 17.3% in Chad, a difference of 1.6%.
That makes Niger's figure about 1.1 times Chad's.
Across all 6 years both countries report, Niger has been ahead every year.
Chad ranks 164th and Niger ranks 161st of 184 countries.
Niger has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Chad | Niger | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 10.3% | 13.9% | 3.6% | Niger |
| 2010s | 15.5% | 17.1% | 1.6% | Niger |
| 2020s | 17.3% | 18.7% | 1.3% | Niger |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 5-14, female, Chad or Niger?
- Niger, at 18.9% against 17.3% in Chad as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 5-14, female between Chad and Niger?
- 1.6%, with Niger ahead.
- How many years of comparable data are there for Chad and Niger?
- 6 years are reported by both, from 2000 to 2021.
- How do Chad and Niger rank globally for cause of death, by non-communicable diseases, ages 5-14, female?
- Chad ranks 164th and Niger ranks 161st of 184 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 5-14, female (% of total female deaths ages 5-14). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of female deaths ages 5-14 due to non-communicable diseases divided by number of all female deaths ages 5-14, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.